Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Catalyst Pharm Inc (CPRX)

Catalyst Pharm Inc (CPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 444,736
  • Shares Outstanding, K 103,427
  • Annual Sales, $ 102,310 K
  • Annual Income, $ 31,880 K
  • 60-Month Beta 1.95
  • Price/Sales 4.75
  • Price/Cash Flow 15.05
  • Price/Book 4.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.08
  • Number of Estimates 5
  • High Estimate 0.10
  • Low Estimate 0.05
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.92 +5.23%
on 07/31/20
5.19 -20.52%
on 07/09/20
-0.68 (-14.24%)
since 07/02/20
3-Month
3.92 +5.23%
on 07/31/20
5.19 -20.52%
on 07/09/20
-0.47 (-10.33%)
since 05/01/20
52-Week
2.55 +61.76%
on 03/13/20
7.67 -46.22%
on 09/11/19
-0.93 (-18.48%)
since 08/02/19

Most Recent Stories

More News
Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 11th, 2020

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating,...

CPRX : 4.11 (-4.42%)
Catalyst Pharmaceuticals Comments on Magistrate Judge's Report and Recommendation in its Lawsuit against the FDA

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), today reported that the Magistrate Judge considering Catalyst's lawsuit against the FDA has filed a Report and Recommendation in which she recommends...

CPRX : 4.11 (-4.42%)
Earnings Preview: Catalyst Pharmaceutical (CPRX) Q2 Earnings Expected to Decline

Catalyst (CPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CPRX : 4.11 (-4.42%)
The 3 Most Popular Pharmaceutical Stocks on the Robinhood 100

Pharma stocks have a great deal of potential given the aging population and demand for better treatments. Inovio Pharmaceuticals (INO), Pfizer (PFE), and Catalyst Pharmaceuticals (CPRX) are three of the...

INO : 19.88 (+2.26%)
PFE : 38.39 (-0.23%)
CPRX : 4.11 (-4.42%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Catalyst Pharmaceuticals, Inc. - CPRX

New York, New York--(Newsfile Corp. - July 16, 2020) - Levi & Korsinsky announces it has commenced an investigation of Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) concerning possible breaches of fiduciary...

CPRX : 4.11 (-4.42%)
Catalyst Pharmaceuticals Appoints Jeffrey Del Carmen as Chief Commercial Officer

-Pete Curry has been Promoted to Vice President of Sales

CPRX : 4.11 (-4.42%)
Catalyst (CPRX) Down 0.4% Since Last Earnings Report: Can It Rebound?

Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CPRX : 4.11 (-4.42%)
Catalyst Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating,...

CPRX : 4.11 (-4.42%)
Catalyst (CPRX) Q1 Earnings Beat Estimates, Revenues Miss

Catalyst (CPRX) beats on Q1 earnings but misses on revenues. It also withdraws sales guidance due to the coronavirus pandemic.

SPPI : 3.05 (+2.01%)
CNCE : 9.23 (-0.43%)
TTPH : 2.20 (-3.51%)
CPRX : 4.11 (-4.42%)
Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings Estimates

Catalyst (CPRX) delivered earnings and revenue surprises of 11.11% and -8.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

CPRX : 4.11 (-4.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CPRX with:

Business Summary

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis...

See More

Key Turning Points

2nd Resistance Point 4.81
1st Resistance Point 4.55
Last Price 4.11
1st Support Level 3.98
2nd Support Level 3.67

See More

52-Week High 7.67
Fibonacci 61.8% 5.71
Fibonacci 50% 5.11
Fibonacci 38.2% 4.51
Last Price 4.11
52-Week Low 2.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar